Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons

Journal of Infectious Diseases

Volumn 210, Issue 2, 2014, Pages 234-243

  Shepherd, Leah ^a   Souberbielle, Jean Claude ^b   Bastard, Jean Philippe ^c,d,e   Fellahi, Soraya ^c,d,e   Capeau, Jaqueline ^c,d,e   Reekie, Joanne ^a,f   Reiss, Peter ^g   Blaxhult, Anders ^h   Bickel, Markus ⁱ   Leen, Clifford ^j,k   Kirk, Ole ^l,m   Lundgren, Jens D ^l,m   Mocroft, Amanda ^a   Viard, Jean Paul ⁿ  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL TENON   (France)

^d INSERM   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ HIVCENTER Haus 68   (Germany)

^j WESTERN GENERAL HOSPITAL   (United Kingdom)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l UNIVERSITY OF COPENHAGEN   (Denmark)

^m Rigshospitalet   (Denmark)

ⁿ HÔTEL DIEU   (France)

more..

Author keywords

soluble CD14

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CD14 ANTIGEN; EFAVIRENZ; INTERLEUKIN 6; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALL CAUSE MORTALITY; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL MODEL; VITAMIN SUPPLEMENTATION;

ALL-CAUSE DEATH; C-REACTIVE PROTEIN; HIV; IL-6; INFLAMMATION; SOLUBLE CD14; VITAMIN D;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VITAMIN D;

EID: 84904002343     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu074     Document Type: Article

References (47)

1. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80:1689s-96s.
2. Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care 2010; 33:2238-43.
3. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K. Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 2008; 168:397-403. (Pubitemid 351350586)
4. Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 2008; 26:2984-91.
5. Pilz S, Dobnig H, Nijpels G, et al. Vitamin D and mortality in older men and women. Clin Endocrinol 2009; 71:666-72.
6. Zittermann A, Schleithoff SS, Gotting C, et al. Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation 2009; 87:118-24.
7. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81.
8. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168:1340-9. (Pubitemid 351930842)
9. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293:2257-64. (Pubitemid 40629192)
10. Viard J, Souberbielle J, Kirk O, et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011; 25:1305-15.
11. Vescini F, Cozzi-Lepri A, Borderi M, et al. Prevalence of hypovitaminosis d and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. JAIDS J Acquired Immune Defic Syndromes 2011; 58:163-72.
12. Mehta S, Giovannucci E, Mugusi FM, et al. Vitamin D status of HIVinfected women and its association with HIV disease progression, anemia, and mortality. PLoS ONE 2010; 5:e8770.
13. Sudfeld CR, Wang ML, Aboud S, Giovannucci EL, Mugusi FM, Fawzi WW. Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy. PLoS ONE 2012; 7:e40036.
14. Kim JH, Gandhi V, Psevdos G, Espinoza F, Park J, Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York City. AIDS Res Hum Retroviruses 2012; 28:235-41.
15. Fox J, Peters B, Prakash M, Arribas J, Hill A, Moecklinghoff C. Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial. AIDS Res Hum Retroviruses 2011; 27:29-34.
16. Dao CN, Patel P, Overton ET, et al. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis 2011; 52:396-405.
17. Adeyemi OM, Agniel D, French AL, et al. Vitamin D deficiency in HIVinfected and un-infected women in the US. JAIDS J Acquired Immune Defic Syndromes 2011; 57:197-204.
18. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8:685-98.
19. von Essen MR, Kongsbak M, Schjerling P, Olgaard K, Odum N, Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 2010; 11:344-9.
20. Bikle DD. Vitamin D regulation of immune function. Vitam Horm 2011; 86:1-21.
21. Kuller LH, Tracy R, BellosoW, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS med 2008; 5:1496-508.
22. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003; 114:180-7. (Pubitemid 36294002)
23. Boxer RS, Dauser DA, Walsh SJ, Hager WD, Kenny AM. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 2008; 56:454-61. (Pubitemid 351327953)
24. Murr C, Pilz S, Grammer TB, et al. Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chem Lab Med 2012; 50:2205-12.
25. Ansemant T, Mahy S, Piroth C, et al. Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients. Bmc Infect Dis 2013; 13:7.
26. Zhang Y, Leung DYM, Richers BN, et al. Vitamin D inhibits monocyte/ macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 2012; 188:2127-35.
27. Sattar N, Welsh P, Panarelli M, Forouhi NG. Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 2012; 379:95-6.
28. Mocroft A, Reiss P, Gasiorowski J, et al. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. JAIDS J Acquired Immune Defic Syndromes 2010; 55:262-70.
29. Kowalska JD, Friis-Moller N, Kirk O, et al. The coding causes of death in HIV (CoDe) project initial results and evaluation of methodology. Epidemiology 2011; 22:516-23.
30. Hollis BW. Comparison of commercially available I-125-based RIA methods for the determination of circulating hydroxyvitamin D. Clin Chem 2000; 46:1657-61.
31. Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O. SAS for mixed models. 2nd ed. Cary, NC: SAS Institute Inc, 2006.
32. Ginde AA, Liu MC, Camargo CA. demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169:626-32.
33. Conesa-Botella A, Florence E, Lutgarde L, Colebunders R, Menten J, Moreno-Reyes R. Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther 2010; 7:40.
34. Brown TT, McComsey GA. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 2010; 15:425-9.
35. Rodger AJ, Fox Z, Lundgren JD, et al. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J Infect Dis 2009; 200:973-83.
36. Hyppönen E, Hyppönen D, Berry M, Cortina Borja C, Power P, Reitsma. 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British birth cohort. PLoS ONE 2010; 5:e10801.
37. Schleithoff SS, Zitterman A, Tenderich G, Berthold H, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006; 83:754-9. (Pubitemid 44713136)
38. Aziz M, Livak B, Burke-Miller J, et al. Vitamin D insufficiency may impair CD4 recovery among women's interagency HIV Study participants with advanced disease on HAART. AIDS 2013; 27:573-8.
39. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al. Vitamin Ddeficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008; 24:1375-82.
40. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011; 203:780-90.
41. Hutcheon JA, Chiolero A, Hanley JA. Random measurement error and regression dilution bias. BMJ 2010; 340:c2289.
42. Crothers K, Goulet JL, Rodriguez-Barradas MC, et al. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev 2009; 21:40-53.
43. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer 2009; 9:655-64.
44. Allavena C, Delpierre C, Cuzin L, et al. High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J Antimicrob Chemother 2012; 67:2222-30.
45. Crutchley RD, Gathe J, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res Hum Retroviruses 2012; 28:454-9.
46. Foissac F, Treluyer JM, Souberbielle JC, Rostane H, Urien S, Viard JP. Vitamin D3 supplementation scheme in HIV-infected patients based upon pharmacokinetic modelling of 25-hydroxycholecalciferol. Brit J Clin Pharmaco 2012; 75:1312-20.
47. Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA 2012; 109:15449-54.